Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Narcolepsy With Cataplexy”

53 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 53 results

Large-scale testing (Phase 3)Study completedNCT06470828
What this trial is testing

TAK-861 for the Treatment of Narcolepsy Type 1

Who this might be right for
Narcolepsy Type 1
Takeda 168
Early research (Phase 1)Study completedNCT05015673
What this trial is testing

This is a Study to Determine the Effect of Multiple Doses of an Investigational Drug, Taken by Mouth, in People With Narcolepsy-cataplexy. Accepting Both Males and Females Ages of 18 Years to 55 Years. This Study Will be Conducted in the US and Will Require Approximately 13 Weeks Participation.

Who this might be right for
Narcolepsy
Otsuka Pharmaceutical Development & Commercialization, Inc. 18
Large-scale testing (Phase 3)UnknownNCT05914194
What this trial is testing

A Eight-Week Study of NLS-2 (Mazindol Extended Release) in Participants With Narcolepsy Type 1

Who this might be right for
Narcolepsy Type 1Narcolepsy With Cataplexy
NLS Pharmaceutics 48
Large-scale testing (Phase 3)Study completedNCT00078377
What this trial is testing

Safety and Efficacy Study of Armodafinil (CEP-10953) in the Treatment of Excessive Sleepiness Associated With Narcolepsy

Who this might be right for
Narcolepsy
Cephalon 196
Testing effectiveness (Phase 2)Study completedNCT03881852
What this trial is testing

Clinical Outcomes in Narcolepsy and Cataplexy: An Evaluation of Reboxetine Treatment (CONCERT)

Who this might be right for
NarcolepsyCataplexy NarcolepsyExcessive Sleepiness
Axsome Therapeutics, Inc. 21
Large-scale testing (Phase 3)Study completedNCT02221869
What this trial is testing

Study of the Efficacy and Safety of Xyrem With an Open- Label Pharmacokinetic Evaluation and Safety Extension in Pediatric Subjects With Narcolepsy With Cataplexy

Who this might be right for
Narcolepsy With Cataplexy
Jazz Pharmaceuticals 106
Large-scale testing (Phase 3)Study completedNCT05113745
What this trial is testing

Assess the Long-term Efficacy and Safety of AXS-12 (Reboxetine) in Subjects With Narcolepsy (ENCORE)

Who this might be right for
NarcolepsyCataplexyExcessive Daytime Sleepiness
Axsome Therapeutics, Inc. 68
Large-scale testing (Phase 3)Looking for participantsNCT07598708
What this trial is testing

Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence

Who this might be right for
Narcolepsy Type 1Narcolepsy Type 2
Centessa Pharmaceuticals (UK) Limited 222
Large-scale testing (Phase 3)Study completedNCT02720744
What this trial is testing

Once-Nightly Sodium Oxybate for Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy

Who this might be right for
Excessive Daytime SleepinessCataplexyNarcolepsy
Avadel 212
Testing effectiveness (Phase 2)Study completedNCT06358950
What this trial is testing

Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Narcolepsy Type 1 (ALKS 2680-201)

Who this might be right for
Narcolepsy Type 1
Alkermes, Inc. 92
Large-scale testing (Phase 3)Active Not RecruitingNCT07363720
What this trial is testing

A Trial of TAK-861 for the Treatment of Narcolepsy With Cataplexy

Who this might be right for
Narcolepsy Type 1 (NT1)Narcolepsy With Cataplexy
Takeda 98
Testing effectiveness (Phase 2)Ended earlyNCT04820842
What this trial is testing

TAK-994 in Adults With Narcolepsy

Who this might be right for
Narcolepsy Type 1 (NT 1)
Takeda 26
Testing effectiveness (Phase 2)Study completedNCT04072380
What this trial is testing

Evaluate Safety, and Efficacy of SUVN-G3031 (Samelisant) in Patients With Narcolepsy With and Without Cataplexy

Who this might be right for
Narcolepsy
Suven Life Sciences Limited 190
Large-scale testing (Phase 3)Study completedNCT01067235
What this trial is testing

Efficacy and Safety Study of BF2.649 and BF2.649 Add on Modafinil on Cataplexy in Patients With Narcolespy

Who this might be right for
NarcolepsyCataplexyExcessive Daytime Sleepiness
Bioprojet 14
Large-scale testing (Phase 3)Looking for participantsNCT07540364
What this trial is testing

Evaluate the Efficacy and Safety of Samelisant in Patients With Narcolepsy (AWAKE)

Who this might be right for
Narcolepsy
Suven Life Sciences Limited 240
Large-scale testing (Phase 3)Study completedNCT04451668
What this trial is testing

An Open Label Study of FT218 in Subjects With Narcolepsy

Who this might be right for
NarcolepsyCataplexyExcessive Daytime Somnolence+3 more
Avadel 184
Testing effectiveness (Phase 2)Study completedNCT04026958
What this trial is testing

Clarithromycin Mechanisms in Hypersomnia Syndromes

Who this might be right for
Narcolepsy Without CataplexyIdiopathic HypersomniaNarcolepsy With Cataplexy
Emory University 83
Not applicableLooking for participantsNCT06383806
What this trial is testing

Decreasing Nightmares in Adults With Narcolepsy

Who this might be right for
NarcolepsyNarcolepsy Type 1Narcolepsy With Cataplexy+3 more
University of Utah 80
Large-scale testing (Phase 3)Looking for participantsNCT07675135
What this trial is testing

Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy

Who this might be right for
EDSCataplexyFatigue+1 more
Harmony Biosciences Management, Inc. 258
Early research (Phase 1)Study completedNCT01093508
What this trial is testing

Single-dose Safety Study of APD916 in Healthy Volunteers

Who this might be right for
Narcolepsy With or Without Cataplexy
Arena Pharmaceuticals 72
Next Page